Moteur de recherche d’entreprises européennes

Financement de l’UE (9 280 000 €) : Gravitate-Health : Donner aux Européens les moyens d’agir et leur fournir des informations sur la santé pour une gestion active de la santé personnelle et l’ … Hor 01/11/2020 Programme de recherche et d'innovation de l'UE « Horizon »

Texte

Gravitate-Health : Donner aux Européens les moyens d’agir et leur fournir des informations sur la santé pour une gestion active de la santé personnelle et l’observance du traitement

The Gravitate-Health mission is to equip and empower citizens with digital information tools that make them confident, active, and responsive in their patient journey, specifically encouraging safe use of medicines for better health outcomes and quality of life. It is our vision that engagement of citizens in their own health can only be achieved with access to actionable, understandable, relevant, reliable and evidence-based information that meets their specific needs, health context, and literacy level. This project's ambition is to provide a key piece to advance this vision: the Gravitate Lens (G-lens), which focuses (but does not conceal or filter) approved electronic product information (ePI) content, and offers a route for patients to access trustworthy, up-to-date information that better meet their individual needs. Gravitate-Health is an integrated digital health information project. The principle objective is to demonstrate how use of an integrated, digital, user-centric health information solution with two-way communication could enable tangible improvements in availability and understanding of health information from a set of trusted sources, starting with regulator-approved medicinal product information (e.g. package leaflet content) and EHR-IPS (International Patient Summary). The secondary objectives are to demonstrate that the improved availability and understanding of health information from trusted sources translate to higher levels of adherence to treatment, safer use of medication (Pharmacovigilance), better health outcomes and quality of life, and to develop new and deeper insights into how use of available health information can be optimized to act as effective risk minimization measures. The project allows for efficient and timely development of the G-lens, provides testing grounds for new services and an evaluation framework to test the efficiency, efficacy and safety of Gravitate-Health services. Our main outputs will be an open source digital platform supporting G-lens functionally, demonstrated in a number of testing scenarios, and a White Paper with recommendations on realistic strategies to strengthen access, understanding and future use of digital services like ePIs as a tool for Risk Minimization. The Gravitate-Health is a public – private partnership with 45 members from Europe and the US, co-led by University of Oslo (coordinator) and Pfizer (industry lead), funded by the Innovative Medicines Initiative (IMI) – a joint undertaking of the European Commission, the European Federation of Pharmaceutical Industries and Associations (EFPIA), IMI Associated Partners.


Agencia Espanola de Medicamentos y Productos Sanitarios 70 000 €
Agentschap College TER Beoordeling Van Geneesmiddelen 197 375 €
Akershus Universitetssykehus HF 344 375 €
Astrazeneca AB 0,00 €
Bayer AG 0,00 €
Beth Israel Deaconess Medical Center, INC NON Profit Corporation 0,00 €
Datapharm Ltd. 0,00 €
Datawizard Srl 402 313 €
Direktoratet FOR Medisinske Produkter 1 325,18 €
DLI - Dansk Laegemiddel Information A/S 22 501 €
Echalliance CLG 286 500 €
Eli Lilly and Company Ltd. 0,00 €
Empirica Gesellschaft FUR Kommunikations UND Technologieforschung mbH 534 554 €
F. Hoffmann-LA Roche AG 0,00 €
Felleskatalogen AS 33 751 €
Forum des Patients Europeens 302 725 €
Frisq Holding AB 106 838 €
Grunenthal GmbH 0,00 €
Guardtime OÜ 117 656 €
Himss Europe GmbH 268 375 €
HL7 Europe 729 429 €
Janssen Pharmaceutica N.V. 0,00 €
Karolinska Institutet 367 466 €
Kobenhavns Universitet 126 250 €
Lakemedelsindustriforeningens Service AB 22 501 €
Mdsol Europe Ltd. 0,00 €
Mindview Symvouloi Epixeiriseon Kaierevnas Etaireia Periorismenis Efthynis 149 625 €
Mylan IRE Healthcare Ltd. 0,00 €
Norsk E Helse AS 296 250 €
Novartis Pharma AG 0,00 €
Open Evidence 61 107 €
Oslo Universitetssykehus HF 155 000 €
Pfizer Ltd. 0,00 €
Pharmaca Health Intelligence Oy 22 501 €
Predictby Research And Consulting SL 296 345 €
Servicio Madrileno de Salud 142 481 €
SPMS - Servicos Partilhados do Ministerio da Saude ΕΠΕ 141 000 €
Synergist Services 0,00 €
THE European Institute for Innovation Through Health Data 273 304 €
The Provost, Fellows Foundation Scholars & the Other Members of Board, of the College of the Holy & Undivided Trinity of Queen Elizabeth Near Dublin 336 491 €
THE Synergist 249 000 €
Trifork Digital Health AS 431 407 €
UCB Biopharma 0,00 €
Universidad Politecnica de Madrid 609 554 €
Universita Cattolica Del Sacro Cuore 151 813 €
Universitetet I Oslo 1 860 565 €
Universitetssykehuset Nord-Norge HF 163 750 €
University College Dublin, National University of Ireland, Dublin 5 875,00 €

https://cordis.europa.eu/project/id/945334

Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel.